Safety and Tolerability of an Inhaled Galectin-3 Inhibitor in Patients With COVID-19 Pneumonitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Respiratory and Critical Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
Am J Respir Crit Care Med 2023 Jan 15;207(2)138-149, EE Gaughan, TM Quinn, A Mills, AM Bruce, J Antonelli, AC MacKinnon, V Aslanis, F Li, R O'Connor, C Boz, R Mills, P Emanuel, M Burgess, G Rinaldi, A Valanciute, B Mills, E Scholefield, G Hardisty, EG Findlay, RA Parker, J Norrie, JW Dear, AR Akram, O Koch, K Templeton, DH Dockrell, TS Walsh, S Partridge, D Humphries, J Wang-Jairaj, RJ Slack, H Schambye, D Phung, L Gravelle, B Lindmark, M Shankar-Hari, N Hirani, T Sethi, K DhaliwalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.